Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolyn Tallon

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Neural Regeneration Research|November 25, 2017
Beta secretase activity in peripheral nerve regenerationCarolyn Tallon, Mohamed H Farah
Neurobiology of Disease|July 9, 2017
Increased BACE1 activity inhibits peripheral nerve regeneration after injuryCarolyn Tallon, Edward Rockenstein, Eliezer Masliah, et al.
ACS Chemical Neuroscience|October 14, 2020
Sowing the Seeds of Discovery: Tau-Propagation Models of Alzheimer's DiseaseBenjamin J Bell, Medhinee M Malvankar, Carolyn Tallon, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 3, 2020
Pharmacological BACE Inhibition Improves Axonal Regeneration in Nerve Injury and Disease ModelsCarolyn Tallon, Katherine L Marshall, Matthew E Kennedy, et al.
ACS Medicinal Chemistry Letters|December 15, 2022
Effects of 6-Aminonicotinic Acid Esters on the Reprogrammed Epigenetic State of Distant Metastatic Pancreatic CarcinomaRun-Duo Gao, Masahiro Maeda, Carolyn Tallon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentCarolyn Tallon, Sebastien Pradel, Koya Yakabi, et al.
European Journal of Immunology|July 17, 2021
Regulatory T cells reduce endothelial neutral sphingomyelinase 2 to prevent T-cell migration into tumorsPaulina Akeus, Louis Szeponik, Veronica Langenes, et al.
Drug Discovery Today|April 2, 2021
Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseasesCarolyn Tallon, Kristen R Hollinger, Arindom Pal, et al.
Journal of Alzheimer'S Disease : JAD|July 18, 2020
Glutamine Antagonist JHU-083 Normalizes Aberrant Hippocampal Glutaminase Activity and Improves Cognition in APOE4 MiceKristen R Hollinger, Xiaolei Zhu, Elizabeth S Khoury, et al.
Biochemical Pharmacology|October 22, 2021
Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injuryCarolyn Tallon, Silvia Picciolini, Seung-Wan Yoo, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Neural Regeneration Research|November 25, 2017
Beta secretase activity in peripheral nerve regenerationCarolyn Tallon, Mohamed H Farah
Neurobiology of Disease|July 9, 2017
Increased BACE1 activity inhibits peripheral nerve regeneration after injuryCarolyn Tallon, Edward Rockenstein, Eliezer Masliah, et al.
ACS Chemical Neuroscience|October 14, 2020
Sowing the Seeds of Discovery: Tau-Propagation Models of Alzheimer's DiseaseBenjamin J Bell, Medhinee M Malvankar, Carolyn Tallon, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 3, 2020
Pharmacological BACE Inhibition Improves Axonal Regeneration in Nerve Injury and Disease ModelsCarolyn Tallon, Katherine L Marshall, Matthew E Kennedy, et al.
ACS Medicinal Chemistry Letters|December 15, 2022
Effects of 6-Aminonicotinic Acid Esters on the Reprogrammed Epigenetic State of Distant Metastatic Pancreatic CarcinomaRun-Duo Gao, Masahiro Maeda, Carolyn Tallon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentCarolyn Tallon, Sebastien Pradel, Koya Yakabi, et al.
European Journal of Immunology|July 17, 2021
Regulatory T cells reduce endothelial neutral sphingomyelinase 2 to prevent T-cell migration into tumorsPaulina Akeus, Louis Szeponik, Veronica Langenes, et al.
Drug Discovery Today|April 2, 2021
Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseasesCarolyn Tallon, Kristen R Hollinger, Arindom Pal, et al.
Journal of Alzheimer'S Disease : JAD|July 18, 2020
Glutamine Antagonist JHU-083 Normalizes Aberrant Hippocampal Glutaminase Activity and Improves Cognition in APOE4 MiceKristen R Hollinger, Xiaolei Zhu, Elizabeth S Khoury, et al.
Biochemical Pharmacology|October 22, 2021
Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injuryCarolyn Tallon, Silvia Picciolini, Seung-Wan Yoo, et al.
Pageof 2